Search Images Maps Play YouTube News Gmail Drive More »
Settings | Sign in

Hepatocellular carcinoma

New hepatocellular carcinoma prognostic model improves prediction of patient survival

Science Daily - ‎Apr 26, 2016‎
Primary liver cancer is the sixth most common cancer and the second leading cause of cancer-related deaths worldwide. Current prognostic models for HCC (the most common liver cancer) do not integrate a number of patient-level factors that affect ...
See realtime coverage

Risk Factors for Hepatocellular Carcinoma

OncLive - ‎Apr 27, 2016‎
Richard Finn, MD: Yes, I think, obviously, regionally across the country, we see differences in liver cancer etiology. Certainly, I think in the US, as you commented, hepatitis C dominates.

Multidisciplinary Care in Hepatocellular Carcinoma

OncLive - ‎Apr 22, 2016‎
The disease burden of hepatocellular carcinoma continues to increase, not only because of its aggressive nature, but also because the incidence of cirrhosis is rising.

Hepatocellular carcinoma incidence to increase through 2030

Healio - ‎Apr 21, 2016‎
Treatment of hepatitis C virus infections with second-generation direct-acting antivirals has the potential to dramatically decrease these trends.

Novel Therapies on the Horizon in Hepatocellular Carcinoma

Targeted Oncology - ‎Apr 19, 2016‎
Both in the United States and worldwide, the incidence of hepatocellular carcinoma (HCC) is on the rise, and, despite extensive research, sorafenib (Nexavar) remains the only FDA-approved systemic therapy available for advanced tumors.

Global Metastatic Hepatocellular Carcinoma (HCC) Pipeline Review 2016 - Research and Markets

Business Wire (press release) - ‎Apr 19, 2016‎
This report provides comprehensive information on the therapeutic development for Metastatic Hepatocellular Carcinoma (HCC), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route ...
See realtime coverage

Metastatic Hepatocellular Carcinoma (HCC) Therapeutics and Drug Pipeline Review H1 2016 (blog) - ‎Apr 19, 2016‎ adds “Metastatic Hepatocellular Carcinoma (HCC) Therapeutics and Drug Pipeline Review H1 2016” report to its research database.

Hepatocellular Carcinoma Clinical Trials Review 2016 By Global Market Research Store (blog) - ‎Apr 17, 2016‎
Hepatocellular-CarcinomaHepatocellular Carcinoma Worldwide 2016 Clinical Trials Review, H2” includes an compalete overview of Hepatocellular Carcinoma scenario. This Hepatocellular Carcinoma report provides data relating on Hepatocellular ...

Fructose Metabolism Offers Potential New Target for Hepatocellular Cancer Diagnosis and Treatment (blog) - ‎Apr 24, 2016‎
Dr. Lu: Among primary liver cancers, hepatocellular carcinoma (HCC) is the most common histological subtype, accounting for 70-85% of all cases.

New report examines the global metastatic hepatocellular carcinoma (hcc) 2016

WhaTech - ‎Apr 26, 2016‎
The report provides comprehensive information on the therapeutics under development for Metastatic Hepatocellular Carcinoma (HCC), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) ...

New Trends of Hepatocellular Carcinoma HCC Treatment Market with Worldwide Industry Analysis to 2026

NewsMaker (press release) - ‎Apr 17, 2016‎
Hepatocellular carcinoma (HCC) is also known as malignant hepatoma. HCC is the major malignancy of the liver and is found to occur mainly in patients with chronic liver diseases and cirrhosis.

Cup of joy: Drink black coffee daily to cut liver disease risk

Hindustan Times - ‎22 hours ago‎
Studies suggest that the incidence of advanced fibrosis and cirrhosis is lower among coffee drinkers. The risk of liver cancer is also lower in coffee drinkers compared to non-coffee consuming population. (Shutterstock) ...

$7.5 million to be pumped into liver cancer research

The Straits Times - ‎Apr 27, 2016‎
SINGAPORE - A Singapore-based team researching the most common type of liver cancer has been awarded a $7.5 million grant to continue its studies, it was announced on Wednesday.

People treated for hepatitis C have unexpectedly high rate of liver cancer recurrence

aidsmap - ‎Apr 29, 2016‎
Hepatitis C patients with cirrhosis who were treated with direct-acting antivirals had about twice the expected likelihood of developing hepatocellular carcinoma (HCC), with the excess risk seen in people with a previous history of HCC, according to ...

Metastectomies: Local Approaches to Breast Cancer Metastases

Medscape - ‎Apr 28, 2016‎
"Metastectomies" are becoming increasingly common in other solid tumors, such as colorectal cancer, lung cancer, and sarcoma, she noted, and "we are trying to change the paradigm in breast cancer." Liver metastases are usually associated with other ...

Successful treatment for hepatitis C reduces risk of liver cancer later in veterans

Medical Xpress - ‎Apr 25, 2016‎
A new study by researchers at Baylor College of Medicine found that treatment and cure of chronic hepatitis C reduce the risk of hepatocellular carcinoma (HCC), especially if given early, before cirrhosis develops, and while patients are still young ...

Black Coffee Daily Can Cut Liver Disease Risk: Experts

NDTV - ‎Apr 28, 2016‎
People who consume more than two cups of coffee per day with pre-existing liver disease have shown lower incidence of fibrosis and cirrhosis, lower Hepatocellular carcinoma (HCC) rates - the most common type of liver cancer -- as well as decreased ...

Nigerian Cancer Patient Treated at Bengaluru City Hospital

The New Indian Express - ‎Apr 28, 2016‎
BENGALURU: A Nigerian national was successfully operated upon to completely eradicate metastasis liver cancer, at Fortis Hospital, Bannerghatta Road, recently.

Dr. Geschwind on Locoregional Therapy for Patients With Liver Cancer

OncLive - ‎Apr 26, 2016‎
Jeff Geschwind, MD, professor and chairman, Radiology and Biomedical Imaging, Yale Cancer Center, discusses locoregional treatment options for patients with hepatocellular carcinoma (HCC). Regardless of whether a patient has localized or metastatic ...

Novel Agents on Horizon for Advanced HCC

OncLive - ‎Apr 26, 2016‎
A number of novel therapies are currently being explored as second-line treatments for patients with advanced hepatocellular carcinoma (HCC), including a host of targeted therapies and various immune checkpoint inhibitors, according to Ghassan Abou ...